Passage Bio earnings were -$68.8M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest PASG earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$19.3M, up 20.9% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, PASG reported annual earnings of -$102.1M, with -25% growth. The next PASG earnings date is Mar 3, 2025.
On PASG's earnings call on Invalid Date, Passage Bio (NASDAQ: PASG) reported Q3 2024 earnings per share (EPS) of -$0.31, up 36.73% year over year. Total PASG earnings for the quarter were -$19.34 million. In the same quarter last year, Passage Bio's earnings per share (EPS) was -$0.49.
The next PASG earnings date is Invalid Date. Add PASG to your watchlist to be reminded of Passage Bio's next earnings date.
What was PASG's earnings growth in the past year?
As of Passage Bio's earnings date in Invalid Date, Passage Bio's earnings has grown year over year. PASG earnings in the past year totalled -$68.80 million.
Is Passage Bio profitable or losing money?
As of the last Passage Bio earnings report, Passage Bio is currently losing money. Passage Bio's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$68.80 million, a 38.78% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.